Leigh MacMillan Archive — Page 53 of 84
-
August 3, 2016
Fetal impact of antidepressants
Antidepressant use during pregnancy is common. Fetal exposure to the class of antidepressants known as selective serotonin reuptake inhibitors (SSRIs) is associated with the life-threatening condition PPHN (persistent pulmonary hypertension of the newborn), but a causal link has not been established. -
August 2, 2016
Refining neural circuitry
During development, neural circuits are remodeled – some synapses are eliminated and others are strengthened – to produce a mature, functional nervous system. -
July 28, 2016
Marrow cells’ role in pulmonary hypertension explored
Cells from the bone marrow participate in the development of pulmonary arterial hypertension (PAH), and they can also protect against it, according to new findings from a team of Vanderbilt University Medical Center investigators. -
July 15, 2016
Work together to control diabetes
Parenting behaviors may be an important target for improving outcomes in adolescents with diabetes. -
June 23, 2016
VU takes key role in cancer drug discovery consortium
Vanderbilt University has been selected as one of seven Dedicated Centers in the nation for the next phase of the Chemical Biology Consortium (CBC), a national network of scientists on the leading edge of cancer drug discovery. -
June 6, 2016
Pulmonary fibrosis culprits
New findings identify isoketal-modified proteins as a previously unrecognized feature of pulmonary fibrosis and as a potential therapeutic target for this disease.